149 related articles for article (PubMed ID: 11028942)
21. Bioequivalence study comparing a new paracetamol solution for injection and propacetamol after single intravenous infusion in healthy subjects.
Flouvat B; Leneveu A; Fitoussi S; Delhotal-Landes B; Gendron A
Int J Clin Pharmacol Ther; 2004 Jan; 42(1):50-7. PubMed ID: 14756388
[TBL] [Abstract][Full Text] [Related]
22. Acetaminophen and tramadol hydrochloride-loaded soft gelatin capsule: preparation, dissolution and pharmacokinetics in beagle dogs.
Cho JH; Choi HG
Pharm Dev Technol; 2021 Jun; 26(5):576-581. PubMed ID: 33719822
[TBL] [Abstract][Full Text] [Related]
23. The impact of formulation and process changes on in vitro dissolution and the bioequivalence of piroxicam capsules.
Piscitelli DA; Bigora S; Propst C; Goskonda S; Schwartz P; Lesko LJ; Augsburger L; Young D
Pharm Dev Technol; 1998 Nov; 3(4):443-52. PubMed ID: 9834946
[TBL] [Abstract][Full Text] [Related]
24. Enhancing the Dissolution Stability of Hard Gelatin Capsules Using Activated Carbon as a Packaging Component.
Likar MD; Carroll SC; Colgan ST; Yeoh T; MacDonald BC; Johnson GM; Space JS
J Pharm Sci; 2018 Dec; 107(12):3080-3088. PubMed ID: 30145210
[TBL] [Abstract][Full Text] [Related]
25. The effect of the composition of a fixed dose combination on bioequivalence results.
Šalandová J; Franc A; Hofmann J; Dumicic A; Kukačková L; Červená T; Beránek J; Srbek J; Repický A; Vladovičová B; Vetchý D
Int J Pharm; 2018 Jul; 546(1-2):235-246. PubMed ID: 29758343
[TBL] [Abstract][Full Text] [Related]
26. Influence of enzymes and surfactants on the disintegration behavior of cross-linked hard gelatin capsules during dissolution.
Pennings FH; Kwee BL; Vromans H
Drug Dev Ind Pharm; 2006 Jan; 32(1):33-7. PubMed ID: 16455602
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier.
Hussein A; El-Menshawe S; Afouna M
Pharmazie; 2012 Mar; 67(3):209-14. PubMed ID: 22530301
[TBL] [Abstract][Full Text] [Related]
28. Bioequivalence and Safety of Twice-Daily Sustained-Release Paracetamol (Acetaminophen) Compared With 3- and 4-Times-Daily Paracetamol: A Repeat-Dose, Crossover Pharmacokinetic Study in Healthy Volunteers.
Liu DJ; Collaku A
Clin Pharmacol Drug Dev; 2018 Jan; 7(1):77-86. PubMed ID: 28815997
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of correlation between gelatin crosslinking indicators and influence factors].
Liu JP; Ma X; Zhu JB
Yao Xue Xue Bao; 2005 Mar; 40(3):279-84. PubMed ID: 15952604
[TBL] [Abstract][Full Text] [Related]
30. Bioavailability study of paracetamol tablets in saliva and urine.
Retaco P; González M; Pizzorno MT; Volonté MG
Eur J Drug Metab Pharmacokinet; 1996; 21(4):295-300. PubMed ID: 9074893
[TBL] [Abstract][Full Text] [Related]
31. Bioequivalence evaluation of menthol after oral administration of peppermint oil soft capsules in dogs.
Wu JF; Xiang BR; Li KX
Arzneimittelforschung; 2010; 60(8):479-82. PubMed ID: 20863003
[TBL] [Abstract][Full Text] [Related]
32. Use of Activated Carbon in Packaging to Attenuate Formaldehyde-Induced and Formic Acid-Induced Degradation and Reduce Gelatin Cross-Linking in Solid Dosage Forms.
Colgan ST; Zelesky TC; Chen R; Likar MD; MacDonald BC; Hawkins JM; Carroll SC; Johnson GM; Space JS; Jensen JF; DeMatteo VA
J Pharm Sci; 2016 Jul; 105(7):2027-31. PubMed ID: 27262203
[TBL] [Abstract][Full Text] [Related]
33. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
[TBL] [Abstract][Full Text] [Related]
34. Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model.
Vardakou M; Mercuri A; Naylor TA; Rizzo D; Butler JM; Connolly PC; Wickham MS; Faulks RM
Int J Pharm; 2011 Oct; 419(1-2):192-9. PubMed ID: 21843611
[TBL] [Abstract][Full Text] [Related]
35. Enzymes in the dissolution testing of gelatin capsules.
Marques MR
AAPS PharmSciTech; 2014 Dec; 15(6):1410-6. PubMed ID: 24942315
[TBL] [Abstract][Full Text] [Related]
36. Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus.
Garbacz G; Cadé D; Benameur H; Weitschies W
Eur J Pharm Sci; 2014 Jun; 57():264-72. PubMed ID: 24021609
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs.
Galia E; Nicolaides E; Hörter D; Löbenberg R; Reppas C; Dressman JB
Pharm Res; 1998 May; 15(5):698-705. PubMed ID: 9619777
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of dissolution test for ritonavir soft gelatin capsules based on in vivo data.
Rossi RC; Dias CL; Donato EM; Martins LA; Bergold AM; Fröehlich PE
Int J Pharm; 2007 Jun; 338(1-2):119-24. PubMed ID: 17343999
[TBL] [Abstract][Full Text] [Related]
39. Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers.
Bittner B; Riek M; Holmes B; Grange S
Antivir Ther; 2005; 10(7):803-10. PubMed ID: 16312177
[TBL] [Abstract][Full Text] [Related]
40. 3D Printing and Dissolution Testing of Novel Capsule Shells for Use in Delivering Acetaminophen.
Gaurkhede SG; Osipitan OO; Dromgoole G; Spencer SA; Pasqua AJD; Deng J
J Pharm Sci; 2021 Dec; 110(12):3829-3837. PubMed ID: 34469748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
